NEW TRIAL ENDPOINTS: CAN THE SLOPE OF EGFR DECLINE BE AN EFFECTIVE SURROGATE FOR CLINICAL KIDNEY EVENTS WHEN ACUTE EGFR CHANGES ARE NOT MEDIATED BY GLOMERULAR HAEMODYNAMICS?
NEPHROLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined